STANFORD UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-11-11

Employees: 10K

Market Cap: -

Website: http://www.stanford.edu

Clinical Trials

Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy

Not Applicable

Completed

Conditions: Gestational Diabetes
Diagnoses Disease
Pregnancy in Diabetic
Glucose, High Blood

Interventions: Behavioral: Fasting before gestational diabetes screen
Behavioral: Per oral intake of food and drink

First Posted Date: 2020-09-14

Last Posted Date: 2022-11-21

Lead Sponsor: Stanford University

Target Recruit Count: 200

Registration Number: NCT04547023

Locations: 🇺🇸
Stanford University, Stanford, California, United States

Efficacy of Diuretics in Kidney Disease

Phase 2

Recruiting

Conditions: Chronic Kidney Disease
End Stage Renal Disease

Interventions: Drug: Placebo
Drug: Metolazone

First Posted Date: 2020-09-09

Last Posted Date: 2022-10-03

Lead Sponsor: Stanford University

Target Recruit Count: 50

Registration Number: NCT04542304

Locations: 🇺🇸
VA Palo Alto Health Care System, Palo Alto, California, United States
🇺🇸
Stanford University, Palo Alto, California, United States

Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts

Not Applicable

Active, not recruiting

Conditions: Breast Cancer

Interventions: Device: NACgraft

First Posted Date: 2020-09-01

Last Posted Date: 2024-05-07

Lead Sponsor: Stanford University

Target Recruit Count: 15

Registration Number: NCT04534010

Locations: 🇺🇸
Stanford University, Stanford, California, United States

Medical Mindfulness: Virtual Reality Mindfulness Therapy for Anxiety and Pain Management in Patients With Acute and Chronic Pain

Suspended

Conditions: Chronic Pain
Acute Pain

Interventions: Behavioral: Virtual Reality Mindfulness

First Posted Date: 2020-09-01

Last Posted Date: 2022-08-22

Lead Sponsor: Stanford University

Target Recruit Count: 500

Registration Number: NCT04534101

Locations: 🇺🇸
Stanford University Medical Center, Palo Alto, California, United States

Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD

Not Applicable

Suspended

Conditions: Asperger Syndrome
Autism Spectrum Disorder
Autism

Interventions: Device: Transcranial magnetic stimulation

First Posted Date: 2020-08-31

Last Posted Date: 2024-02-08

Lead Sponsor: Stanford University

Target Recruit Count: 67

Registration Number: NCT04532424

Locations: 🇺🇸
Robin Libove, Stanford, California, United States

Effects of Blood Flow Restriction (BFR) Therapy on ACL Graft Maturation

Not Applicable

Withdrawn

Conditions: Anterior Cruciate Ligament Injuries
Knee Injuries

Interventions: Other: Standard Postoperative Physical Therapy
Other: Blood Flow Restriction Therapy

First Posted Date: 2020-08-27

Last Posted Date: 2024-11-25

Lead Sponsor: Stanford University

Target Recruit Count: 40

Registration Number: NCT04528992

Locations: 🇺🇸
Stanford, Redwood City, California, United States

Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients

Phase 2

Completed

Conditions: Covid19

Interventions: Drug: Camostat Mesilate
Drug: Placebo
Other: Standard of Care Treatment

First Posted Date: 2020-08-24

Last Posted Date: 2022-06-10

Lead Sponsor: Stanford University

Target Recruit Count: 49

Registration Number: NCT04524663

Locations: 🇺🇸
Stanford University, Stanford, California, United States

Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging

Phase 1

Recruiting

Conditions: Cervix Cancer
Endometrial Cancer

Interventions: Diagnostic Test: FDG PET/CT
Drug: GCSF

First Posted Date: 2020-08-17

Last Posted Date: 2023-03-10

Lead Sponsor: Stanford University

Target Recruit Count: 29

Registration Number: NCT04514692

Locations: 🇺🇸
Stanford Cancer Institute Palo Alto, Stanford, California, United States

Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer

Phase 2

Terminated

Conditions: Endometrial Cancer

Interventions: Drug: Lymphoseek
Device: Single Photon Emission Computed Tomography (SPECT)
Drug: Indocyanine Green (ICG)
Device: Neoprobe Gamma Detection System NPB11L(Model1102)

First Posted Date: 2020-08-12

Last Posted Date: 2023-10-11

Lead Sponsor: Stanford University

Target Recruit Count: 6

Registration Number: NCT04511026

Locations: 🇺🇸
Stanford University, School of Medicine, Stanford, California, United States

Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC)

Not Applicable

Active, not recruiting

Conditions: Kidney Cancer
Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma

Interventions: Diagnostic Test: Doppler Ultrasound
Device: SIEMENS S3000 and Verasonics Vantage 256
Drug: Vascular Endothelial Growth Factor Receptor 2 tyrosine kinase inhibitor plus immune checkpoint inhibitor

First Posted Date: 2020-08-11

Last Posted Date: 2024-02-15

Lead Sponsor: Stanford University

Target Recruit Count: 22

Registration Number: NCT04508725

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy